Apyx Medical (APYX) Free Cash Flow (2011 - 2026)

Apyx Medical (APYX) has reported Free Cash Flow for 16 consecutive years, with -$3.6 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Free Cash Flow fell 137.38% year-over-year to -$3.6 million; the trailing twelve-month figure through Jun 2026 stood at -$11.0 million (down 10.15% YoY), and the FY2025 full-year result was -$9.1 million, up 51.44% from the prior year.
• Free Cash Flow declined to -$3.6 million in Q2 2026 per APYX's latest filing, from -$632000.0 in the prior quarter.
• Across five years, Free Cash Flow topped out at $3.5 million in Q3 2023 and bottomed at -$6.4 million in Q1 2024.
• Historically, Free Cash Flow has averaged -$3.3 million across 5 years, with a median of -$3.8 million in 2025.
• The sharpest annual moves came in 2022 and 2023: Free Cash Flow slumped 3859.32% in 2022, then jumped 163.48% in 2023.
• Over 5 years, Free Cash Flow stood at -$4.7 million in 2022, then surged by 50.66% to -$2.3 million in 2023, then sank by 38.05% to -$3.2 million in 2024, then gained by 11.85% to -$2.8 million in 2025, then dropped by 26.77% to -$3.6 million in 2026.
• According to Business Quant data, Free Cash Flow over the past three periods registered -$3.6 million, -$632000.0, and -$2.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.